Spyre Therapeutics (SYRE)

Spyre Therapeutics (SYRE) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• SYRE last traded at $94.99, -1.63% on the day.
• Spyre Therapeutics: P/E -48.6.
• Over the past year SYRE returned 291.55%; year to date 189.96%.

Updated 2026-11-02 18:39 UTC